BIOTECH: TRIUS, OPTIMER SEEKING SHARES OF $32B ANTI-INFECTIVE DRUG MARKET
Firms Making Progress Developing Antibiotics
Monday, October 4, 2010
Emerging from the mounds of data presented at several recent high-level programs on infectious diseases were updates from two publicly traded San Diego drug companies that have collectively raised nearly $400 million to develop narrow-spectrum antibiotics...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in

- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know